News search

A team from the CNIC has discovered the key role of conventional type 1 dendritic cells (cDC1) in atherosclerosis and has developed an experimental therapy with immunosuppressive nanoparticles that slows the progression of the disease in animal models.

Dra. Maria Kontaridis currently serves as the Gordon K. Moe Professor and Chair of Biomedical Research and Translational Medicine, as well as is the Executive Director and Director of Research, at the Masonic Medical Research Institute

Dr. Mariell Jessup is Chief Science and Medical Officer of the American Heart Association

Jianyi «Jay» Zhang,  Chair of the Department of Biomedical Engineering (BME), at University of Alabama -Birmingham (UAB).

Dr. Benjamin L. Prosser is an Associate Professor in the Department of Physiology at the Perelman School of Medicine at the University of Pennsylvania.

Prof. Daniel Ketelhuth leads a research team at the University of Southern Denmark

A study led by the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), in collaboration with the Instituto de Investigación Biomédica de Barcelona (IRB Barcelona), has identified the most effective subtype of dendritic cell for generating immune memory in response to cancer